Drug intelligence / Profile preview

albizia julibrissin bark

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical (for Skin Conditions)
01

Overview

Albizia julibrissin bark (silktree albizia bark; Chinese name 合欢皮) is the inner stem or trunk bark of the Albizia julibrissin tree. It has a long history of use in Traditional Chinese Medicine (TCM), where it is known as "he huan pi" and is traditionally used to calm the spirit (*shen*), alleviate anxiety and depression, promote restful sleep, and relieve emotional distress. The herb also has applications for trauma-related pain and swelling due to its analgesic and anti-inflammatory properties[1][4][5]. Modern research suggests that its bioactive compounds—such as triterpenoid saponins (notably various julibrosides), flavonoids, lignans, sterols—may contribute to anxiolytic (anti-anxiety), antidepressant, sedative/hypnotic effects as well as antioxidant activity[3][5][9]. Some studies have shown cytotoxic/anticancer effects in vitro via induction of apoptosis in certain cancer cell lines[1][5]. In addition to oral use for mood disorders and insomnia[2], topical preparations are sometimes used for skin infections or trauma. There is insufficient clinical evidence from modern trials supporting these uses.

Other names
silktree albizia bark合欢皮he huan pisilk tree barkAlbizia julibrissin barkPersian silk tree barkmimosa tree bark
02

Targets

HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))GABRR (GABA-A receptor subunit rho)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on albizia julibrissin bark.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albizia julibrissin bark.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call